[
    {
        "molecule_name": "endo oxabicyclic acid ",
        "protein_target_name": "enzyme",
        "binding_metric": "Ki",
        "value": "1.5×10^-7",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences:\n\nUsing that information, Bartlett (Ref. 72) produced a transition state analogue (2.21) which proved to be a powerful inhibitor of the enzyme, Ki of 1.5×10<sup>-7</sup> M, binding much more strongly than chorismate (Km 1.5×10<sup>-5</sup> M for the E.coli enzyme).\nThe enzyme chorismate mutase (EC 5.4.99.5), accelerates the conversion of chorismicacid (2.18) into prephenic acid (2.19) by 3×10<sup>6</sup> and appears to work exclusivelyby restriction of the free rotation of bonds in the substrate, thereby achieving intramolecular juxtaposition of the reacting carbons (FIG. 2D8) (Ref. 70)."
    },
    {
        "molecule_name": "chorismic acid",
        "protein_target_name": "E.coli enzyme",
        "binding_metric": "Km",
        "value": "1.5×10^-5",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences:\n\nUsing that information, Bartlett (Ref. 72) produced a transition state analogue (2.21) which proved to be a powerful inhibitor of the enzyme, Ki of 1.5×10<sup>-7</sup> M, binding much more strongly than chorismate (Km 1.5×10<sup>-5</sup> M for the E.coli enzyme).\nThe enzyme chorismate mutase (EC 5.4.99.5), accelerates the conversion of chorismicacid (2.18) into prephenic acid (2.19) by 3×10<sup>6</sup> and appears to work exclusivelyby restriction of the free rotation of bonds in the substrate, thereby achieving intramolecular juxtaposition of the reacting carbons (FIG. 2D8) (Ref. 70)."
    },
    {
        "molecule_name": "Fluorform",
        "protein_target_name": "TSA (7.37)",
        "binding_metric": "affinity",
        "value": "5.2×10^6",
        "unit": "M^-1",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The results in Appendix A, tables 1 and 2 show that the monoclonal antibodies had a large range of affinities for the two TSAs (7.2 and 7.4), ranging from 10^5 to 10^11 M^-1.\n* One of the antibodies, CF7, showed no binding to the TSA (7.37) in the BIAcore assay but had an affinity of 5.2×10^6 M^-1 in the ELISA.\n* The ELISA was able to determine the aK for this clone because the inhibitor concentration could be lowered to a concentration at which 0% inhibition occurred, with a kd that couldn't be measured due to slow dissociation within the time course of the assay (ca. 5 min).\n* It was found that re-binding was a minimal component of the affinity constant, contributing <15% of the kd. \n\nNote that some sentences may not have a specific numeric value for the metric, or may not have a unit for that value, but the above sentences meet the criteria as they contain a specific molecule name, ID or other identifier, a bioactivity metric, a specific numeric value for that metric, and a unit for that value."
    }
]